Connect Biopharma (ADR) (CNTB)
Develops rademikibart for asthma and COPD outside Greater China.
$1.09
vs last close−0.13 (−10.70%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 22.09% | 13.91M ADS | |
|---|---|---|---|
| 57 holders · as of Jun 30, 2026 | |||
| Insiders | 37.95% | 23.90M ADS | |
| 9 holders · as of Jul 1, 2026 | |||
| Strategic holders | 36.74% | 23.14M ADS | |
| 3 holders · as of Apr 14, 2026 | |||
| Other | 3.22% | 2.03M ADS | |
| remainder | |||
62.97M ADS as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
57 holders · 13.91M shares · 25 new positions · 41 increased · 8 reduced · 9 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ikarian Capital, LLC | 4.54M | 7.21% | −850.0K | Aug 14, 2026 |
| 683 Capital Management, LLC | 1.29M | 2.04% | +385.0K | Aug 14, 2026 |
| Boothbay Fund Management, LLC | 973.7K | 1.55% | −260.9K | Aug 14, 2026 |
| BlackRock, Inc. | 871.7K | 1.38% | +871.7Knew | Aug 7, 2026 |
| Perceptive Advisors LLC | 792.7K | 1.26% | 0 | Aug 14, 2026 |
| Adar1 Capital Management, LLC | 700.0K | 1.11% | −42.4K | Aug 14, 2026 |
| BML Capital Management, LLC | 573.3K | 0.91% | +164.4K | Aug 7, 2026 |
| Silverarc Capital Management, LLC | 545.0K | 0.87% | +545.0Knew | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Panacea Innovation Limited | 25.10% | 13.95M | 13D | Jul 21, 2025 |
| BioFortune Inc | 9.50% | 5.99M | 13G | Apr 14, 2026 |
| Zheng Wei | 9.00% | 5.02M | 13G | Feb 17, 2026 |
| Ikarian Capital, LLC | 8.80% | 4.93M | 13G | Feb 17, 2026 |
| Wei Zheng | 6.20% | 3.88M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 29, 2026 | James Huangdirector | Purchase | 150,000 | $2.48 | 13,310,000 |
| Mar 31, 2026 | James Huangdirector | Purchase | 1,160,000 | $3.45 | 13,160,000 |
House and Senate disclosures
Not reported.